“…Our recent distillation method for removal of osmium from iridium as osmium tetroxide provides an improved technique for removal of the significant levels of Ir-192 produced by the longer irradiation periods required for the production of high specific activity Os-191 in lower flux reactors . Prototypes currently in clinical use include the activated carbon system developed in collaboration between our Nuclear Medicine Group at the Oak Ridge National Laboratory and the Cyclotron Research Center at the University of Liege, Belgium (Brihaye, et al, 1986a(Brihaye, et al, , 1986b(Brihaye, et al, , 1986c(Brihaye, et al, , and 1987, which involves the adsorption of an Os(IV) species on specially treated heat-activated charcoal eluted with pH 2 saline containing 0.025% sodium iodide. In addition, the group at Children's Hospital in Boston has reported the use of Os(VI) species on AGMP-1 eluted with oxalate (Packard et al, 1987), and a group in Soreq, Israel has evaluated the use of Os(VI) bound to silica gel impregnated with tridodecylmethylammonium chloride (SG-TDMAC) (Issacher, et al, 1989 andHellman, et al, 1989).…”